Login / Signup

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients.

Vallari ShahAmy L SherborneDavid C JohnsonSidra EllisAmy PriceFarzana ChowdhuryJack KendallMatthew W JennerMark T DraysonRoger G OwenWalter M GregoryGareth J MorganFaith E DaviesCurly T C M MorrisDavid A CairnsRichard S HoulstonGraham JacksonMartin F Kaisernull null
Published in: Leukemia (2020)
Keyphrases
  • newly diagnosed
  • multiple myeloma
  • end stage renal disease
  • clinical trial
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • single cell
  • phase ii
  • single molecule
  • open label